Inventor · disambiguated record
Troy Mccall
Also filed as: MCCALL TROY · MCCALL TROY W
8 granted patents·15 pending applications·396 citations·filing 1994–2020
90Inventor score
Files withENDO PHARMACEUTICALS INC7KAO HAUI-HUNG3MENDELL CO INC EDWARD3PENWEST PHARMACEUTICALS CO3KAO HUAI-HUNG2
Top patents by PatentIndex Score
23 records- 0196US8309122B2Oxymorphone controlled release formulationsKAO HUAI-HUNG·Filed 2007·Granted Nov 13, 2012·49 cites·20 claims
- 0294US7276250B2Sustained release formulations of oxymorphonePENWEST PHARMACEUTICALS COMPAN·Filed 2002·Granted Oct 2, 2007·64 cites·16 claims
- 0391US8329216B2Oxymorphone controlled release formulationsKAO HAUI-HUNG·Filed 2006·Granted Dec 11, 2012·52 cites·82 claims
- 0488US5662933AControlled release formulation (albuterol)MENDELL CO INC EDWARD·Filed 1995·Granted Sep 2, 1997·80 cites·48 claims
- 0588US5399362AOnce-a-day metoprolol oral dosage formMENDELL CO INC EDWARD·Filed 1994·Granted Mar 21, 1995·99 cites·20 claims
- 0680US5958456AControlled release formulation (albuterol)MENDELL CO INC EDWARD·Filed 1997·Granted Sep 28, 1999·49 cites·16 claims
- 0778US2009192183A1Oxymorphone Controlled Release FormulationsENDO PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0876US9820982B2Oxymorphone controlled release formulationsKAO HUAI-HUNG·Filed 2002·Granted Nov 21, 2017·3 cites·71 claims
- 0976US2008262013A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1075US2021008063A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1175US2015011577A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1274US2018338967A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1371US2014134250A1Oxymorphone controlled release formulationsENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1466US2016136152A1Oxymorphone controlled release compositionsENDO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1565US2007098793A1Oxymorphone controlled release formulationsKAO HAUI-HUNG·Filed 2006·Application pending·0 cites
- 1665US2008050431A1Sustained release formulations of oxymorphonePENWEST PHARMACEUTICALS COMPAN·Filed 2007·Application pending·0 cites
- 1765US2007098792A1Oxymorphone controlled release formulationsKAO HAUI-HUNG·Filed 2006·Application pending·0 cites
- 1852US2014242166A1Sustained release matrix systems for highly soluble drugsPENWEST PHARMACEUTICALS CO·Filed 2014·Application pending·0 cites
- 1951US8679535B2Sustained release matrix systems for highly soluble drugsBAICHWAL ANAND R·Filed 2007·Granted Mar 25, 2014·0 cites·19 claims
- 2050US2007140975A1Opioid formulations having reduced potential for abusePENWEST PHARMACEUTICALS CO·Filed 2007·Application pending·0 cites
- 2148US2003228361A1Sustained release metoprolol formulationsFiled 2003·Application pending·0 cites
- 2246US2004170684A1Sustained release matrix systems for highly soluble drugsPENWEST PHARMACEUTICALS CO·Filed 2003·Application pending·0 cites
- 2344US2003091635A1Opioid formulations having reduced potential for abuseFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Troy Mccall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →